CN102579416B - 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 - Google Patents
卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 Download PDFInfo
- Publication number
- CN102579416B CN102579416B CN 201210044916 CN201210044916A CN102579416B CN 102579416 B CN102579416 B CN 102579416B CN 201210044916 CN201210044916 CN 201210044916 CN 201210044916 A CN201210044916 A CN 201210044916A CN 102579416 B CN102579416 B CN 102579416B
- Authority
- CN
- China
- Prior art keywords
- carmustine
- nose
- rat
- level
- touches
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210044916 CN102579416B (zh) | 2012-02-24 | 2012-02-24 | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210044916 CN102579416B (zh) | 2012-02-24 | 2012-02-24 | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102579416A CN102579416A (zh) | 2012-07-18 |
CN102579416B true CN102579416B (zh) | 2013-10-30 |
Family
ID=46469028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210044916 Active CN102579416B (zh) | 2012-02-24 | 2012-02-24 | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102579416B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101032475A (zh) * | 2007-04-03 | 2007-09-12 | 北京世纪博康医药科技有限公司 | 一种卡莫司汀的药用组合物、制备方法及用途 |
CN101444506A (zh) * | 2008-12-30 | 2009-06-03 | 北京大学 | 雷帕霉素在制备治疗吗啡类药物成瘾的药物上的用途 |
-
2012
- 2012-02-24 CN CN 201210044916 patent/CN102579416B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101032475A (zh) * | 2007-04-03 | 2007-09-12 | 北京世纪博康医药科技有限公司 | 一种卡莫司汀的药用组合物、制备方法及用途 |
CN101444506A (zh) * | 2008-12-30 | 2009-06-03 | 北京大学 | 雷帕霉素在制备治疗吗啡类药物成瘾的药物上的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN102579416A (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rzasa Lynn et al. | Naloxone dosage for opioid reversal: current evidence and clinical implications | |
Volkow | America’s addiction to opioids: Heroin and prescription drug abuse | |
Veilleux et al. | A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction | |
Galinski et al. | Management of severe acute pain in emergency settings: ketamine reduces morphine consumption | |
Brown et al. | General anesthesia and altered states of arousal: a systems neuroscience analysis | |
Carson et al. | Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats | |
Levy | Clinical effects and lethal and forensic aspects of propofol | |
CN106163499A (zh) | 鼻用药物产品及其使用方法 | |
Krivoy et al. | Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: a preliminary study | |
Aceto et al. | MDAN‐21: a bivalent opioid ligand containing mu‐agonist and delta‐antagonist pharmacophores and its effects in rhesus monkeys | |
Volkow | Prescription opioid and heroin abuse | |
Almeida-Santos et al. | The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice | |
Lipman et al. | Substance use disorders and chronic itch | |
CN102143687A (zh) | 4-氨基吡啶在改善具有脱髓鞘和其它神经系统状况的患者的神经-认知和/或神经-精神病学损伤中的用途 | |
Gonzalez et al. | Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults | |
Dart et al. | A randomized, double-blind, placebo-controlled trial of a highly purified equine F (ab) 2 antibody black widow spider antivenom | |
Gerak et al. | Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys | |
CN101827522A (zh) | 持续释放氨基吡啶组合物的使用方法 | |
Crystal et al. | Pharmacokinetic properties of an FDA‐approved intranasal nalmefene formulation for the treatment of opioid overdose | |
Ding et al. | Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates | |
US11103458B2 (en) | Stimulant abuse-deterrent compositions | |
Simonsen et al. | Illustrated pharmacology for nurses | |
CN102579416B (zh) | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 | |
Hur et al. | Abuse potential of synthetic cannabinoids: AM-1248, CB-13, and PB-22 | |
CN111184719B (zh) | 一种多巴胺受体拮抗剂及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Longchuan Inventor before: Yu Longchuan Inventor before: Kong Qingyao |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YU LONGCHUAN KONG QINGYAO TO: YU LONGCHUAN |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: KONG QINGYAO Effective date: 20130328 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130328 Address after: 100091 Beijing city Haidian District Old Summer Palace West Yan Bei yuan 316-308 Applicant after: Yu Longchuan Address before: 100091 Beijing city Haidian District Old Summer Palace West Yan Bei yuan 316-308 Applicant before: Yu Longchuan Applicant before: Kong Qingyao |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |